Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
Share a link:
https://casecent.re/p/21445
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is the eighth of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes German-based Schering AG. During the period 1998-1999, the company conducted business worldwide in four key areas: fertility control and hormone therapy, therapeutics, diagnostics, and dermatology. The case offers a summary of activity in these areas. Revenue and balance sheet information is also provided. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 14 pages
Data source: Published sources
About
Abstract
This is the eighth of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes German-based Schering AG. During the period 1998-1999, the company conducted business worldwide in four key areas: fertility control and hormone therapy, therapeutics, diagnostics, and dermatology. The case offers a summary of activity in these areas. Revenue and balance sheet information is also provided. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Settings
Related
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 14 pages
Data source: Published sources